Operating Lease, Liability, Current of Y-mAbs Therapeutics, Inc. from 31 Mar 2019 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Y-mAbs Therapeutics, Inc. quarterly Operating Lease, Liability, Current in USD history and change rate from 31 Mar 2019 to 30 Jun 2025.
  • Y-mAbs Therapeutics, Inc. Operating Lease, Liability, Current for the quarter ending 30 Jun 2025 was $486,000, a 42% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Y-mAbs Therapeutics, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $486,000 -$356,000 -42% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $455,000 -$433,000 -49% 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $630,000 -$272,000 -30% 31 Dec 2024 10-Q 08 Aug 2025 2025 Q2
Q3 2024 $776,000 -$122,000 -14% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $842,000 +$13,000 +1.6% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $888,000 +$33,000 +3.9% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $902,000 +$34,000 +3.9% 31 Dec 2023 10-K 04 Mar 2025 2024 FY
Q3 2023 $898,000 -$302,000 -25% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $829,000 -$263,000 -24% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q2
Q1 2023 $855,000 -$596,000 -41% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 $868,000 -$915,000 -51% 31 Dec 2022 10-K 29 Feb 2024 2023 FY
Q3 2022 $1,200,000 -$649,000 -35% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $1,092,000 -$922,000 -46% 30 Jun 2022 10-Q 08 Aug 2022 2021 Q3
Q1 2022 $1,451,000 -$520,000 -26% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $1,783,000 -$183,000 -9.3% 31 Dec 2021 10-K 30 Mar 2023 2022 FY
Q3 2021 $1,849,000 -$38,000 -2% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 $2,014,000 +$1,445,000 +254% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $1,971,000 +$1,423,000 +260% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 $1,966,000 +$1,450,000 +281% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $1,887,000 +$1,371,000 +266% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 $569,000 +$67,000 +13% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 $548,000 +$31,000 +6% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $516,000 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $516,000 30 Sep 2019 10-Q 13 Nov 2019 2019 Q3
Q2 2019 $502,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $517,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.